{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:20:46Z","timestamp":1787800846679,"version":"build-2784847793"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10620-026-09964-w","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T10:59:50Z","timestamp":1777978790000},"page":"4221-4234","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative Outcomes of Primary Sclerosing Cholangitis With and Without Comorbid Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9177-7039","authenticated-orcid":false,"given":"Bachviet","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Quon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daljeet","family":"Chahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"9964_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41572-025-00600-x","volume":"11","author":"MP Manns","year":"2025","unstructured":"Manns MP, Bergquist A, Karlsen TH et al. Primary sclerosing cholangitis. Nat Rev Dis Primer. 2025;11:17. https:\/\/doi.org\/10.1038\/s41572-025-00600-x.","journal-title":"Nat Rev Dis Primer."},{"key":"9964_CR2","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1159\/000358150","volume":"32","author":"KD Williamson","year":"2014","unstructured":"Williamson KD, Chapman RW. Primary Sclerosing Cholangitis. Dig Dis. 2014;32:438\u2013445. https:\/\/doi.org\/10.1159\/000358150.","journal-title":"Dig Dis."},{"key":"9964_CR3","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.autrev.2014.01.040","volume":"13","author":"KK Yimam","year":"2014","unstructured":"Yimam KK, Bowlus CL. Diagnosis and classification of primary sclerosing cholangitis. Autoimmun Rev. 2014;13:445\u2013450. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.040.","journal-title":"Autoimmun Rev."},{"key":"9964_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/ajg.2015.112","volume":"110","author":"KD Lindor","year":"2015","unstructured":"Lindor KD, Kowdley KV, Harrison EM. ACG Clinical Guideline: Primary Sclerosing Cholangitis. Am J Gastroenterol. 2015;110:646\u2013659. https:\/\/doi.org\/10.1038\/ajg.2015.112.","journal-title":"Am J Gastroenterol."},{"key":"9964_CR5","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1056\/NEJMra1506330","volume":"375","author":"KN Lazaridis","year":"2016","unstructured":"Lazaridis KN, LaRusso NF. Primary Sclerosing Cholangitis. N Engl J Med. 2016;375:1161\u20131170. https:\/\/doi.org\/10.1056\/NEJMra1506330.","journal-title":"N Engl J Med."},{"key":"9964_CR6","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","volume":"391","author":"JK Dyson","year":"2018","unstructured":"Dyson JK, Beuers U, Jones DEJ, Lohse AW, Hudson M. Primary sclerosing cholangitis. Lancet. 2018;391:2547\u20132559. https:\/\/doi.org\/10.1016\/S0140-6736(18)30300-3.","journal-title":"Lancet."},{"key":"9964_CR7","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.cgh.2021.08.039","volume":"20","author":"PJ Trivedi","year":"2022","unstructured":"Trivedi PJ, Bowlus CL, Yimam KK, Razavi H, Estes C. Epidemiology, Natural History, and Outcomes of Primary Sclerosing Cholangitis: A Systematic Review of Population-based Studies. Clin Gastroenterol Hepatol. 2022;20:1687-1700.e4. https:\/\/doi.org\/10.1016\/j.cgh.2021.08.039.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9964_CR8","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","volume":"152","author":"TJ Weism\u00fcller","year":"2017","unstructured":"Weism\u00fcller TJ, Trivedi PJ, Bergquist A et al. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis. Gastroenterology. 2017;152:1975-1984.e8. https:\/\/doi.org\/10.1053\/j.gastro.2017.02.038.","journal-title":"Gastroenterology."},{"key":"9964_CR9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/hep.32771","volume":"77","author":"CL Bowlus","year":"2023","unstructured":"Bowlus CL, Arriv\u00e9 L, Bergquist A et al. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology. 2023;77:659\u2013702. https:\/\/doi.org\/10.1002\/hep.32771.","journal-title":"Hepatology."},{"key":"9964_CR10","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s10620-019-05484-y","volume":"64","author":"ZP Fricker","year":"2019","unstructured":"Fricker ZP, Lichtenstein DR. Primary Sclerosing Cholangitis: A Concise Review of Diagnosis and Management. Dig Dis Sci. 2019;64:632\u2013642. https:\/\/doi.org\/10.1007\/s10620-019-05484-y.","journal-title":"Dig Dis Sci."},{"key":"9964_CR11","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1093\/ibd\/izad137","volume":"30","author":"A Wittek","year":"2024","unstructured":"Wittek A, Steglich B, Casar C et al. A Gradient of Intestinal Inflammation in Primary Sclerosing Cholangitis. Inflamm Bowel Dis. 2024;30:900\u2013910. https:\/\/doi.org\/10.1093\/ibd\/izad137.","journal-title":"Inflamm Bowel Dis."},{"key":"9964_CR12","doi-asserted-by":"publisher","first-page":"15431","DOI":"10.3390\/ijms242015431","volume":"24","author":"F Rennebaum","year":"2023","unstructured":"Rennebaum F, Demmig C, Schmidt HH et al. Elevated Liver Fibrosis Progression in Isolated PSC Patients and Increased Malignancy Risk in a PSC-IBD Cohort: A Retrospective Study. Int J Mol Sci. 2023;24:15431. https:\/\/doi.org\/10.3390\/ijms242015431.","journal-title":"Int J Mol Sci."},{"key":"9964_CR13","doi-asserted-by":"publisher","unstructured":"Abdalla M, Eberhardson M, Landerholm K, Andersson RE, Myrelid P. Impact of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis on Colorectal Cancer Risk: National Cohort Study. Clin Gastroenterol Hepatol. 2025;S1542356525006214. https:\/\/doi.org\/10.1016\/j.cgh.2025.06.037","DOI":"10.1016\/j.cgh.2025.06.037"},{"key":"9964_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.1435","volume":"7","author":"CJ Sorensen","year":"2024","unstructured":"Sorensen CJ, Fried LP. Defining Roles and Responsibilities of the Health Workforce to Respond to the Climate Crisis. JAMA Netw Open. 2024;7:e241435. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.1435.","journal-title":"JAMA Netw Open."},{"key":"9964_CR15","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1038\/s41591-023-02372-x","volume":"29","author":"DG Shaw","year":"2023","unstructured":"Shaw DG, Aguirre-Gamboa R, Vieira MC et al. Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis. Nat Med. 2023;29:1520\u20131529. https:\/\/doi.org\/10.1038\/s41591-023-02372-x.","journal-title":"Nat Med."},{"key":"9964_CR16","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/j.cgh.2019.07.011","volume":"17","author":"CL Bowlus","year":"2019","unstructured":"Bowlus CL, Lim JK, Lindor KD. AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review. Clin Gastroenterol Hepatol. 2019;17:2416\u20132422. https:\/\/doi.org\/10.1016\/j.cgh.2019.07.011.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9964_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"2021","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, The PRISMA et al. statement: an updated guideline for reporting systematic reviews. BMJ. 2020;2021:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ."},{"key":"9964_CR18","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1001\/jamasurg.2021.0522","volume":"156","author":"BS Brooke","year":"2021","unstructured":"Brooke BS, Schwartz TA, Pawlik TM. MOOSE Reporting Guidelines for Meta-analyses of Observational Studies. JAMA Surg. 2021;156:787. https:\/\/doi.org\/10.1001\/jamasurg.2021.0522.","journal-title":"JAMA Surg."},{"key":"9964_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2024.108602","volume":"186","author":"JPT Higgins","year":"2024","unstructured":"Higgins JPT, Morgan RL, Rooney AA et al. A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E). Environ Int. 2024;186:108602. https:\/\/doi.org\/10.1016\/j.envint.2024.108602.","journal-title":"Environ Int."},{"key":"9964_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","volume":"12","author":"LA McGuinness","year":"2021","unstructured":"McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021;12:55\u201361. https:\/\/doi.org\/10.1002\/jrsm.1411.","journal-title":"Res Synth Methods."},{"key":"9964_CR21","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/hep.26565","volume":"58","author":"K Boonstra","year":"2013","unstructured":"Boonstra K, Weersma RK, Van Erpecum KJ et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis: Boonstra et al. Hepatology. 2013;58:2045\u201355. https:\/\/doi.org\/10.1002\/hep.26565.","journal-title":"Hepatology."},{"key":"9964_CR22","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/j.1365-2036.2012.05063.x","volume":"35","author":"U Navaneethan","year":"2012","unstructured":"Navaneethan U, Venkatesh PGK, Lashner BA, Shen B, Kiran RP. The impact of ulcerative colitis on the long-term outcome of patients with primary sclerosing cholangitis. Aliment Pharmacol Ther. 2012;35:1045\u20131053. https:\/\/doi.org\/10.1111\/j.1365-2036.2012.05063.x.","journal-title":"Aliment Pharmacol Ther."},{"key":"9964_CR23","doi-asserted-by":"publisher","unstructured":"Alsakarneh S, Aburumman R, Bilal M, Faye AS, Hashash JG, Shaukat A. Primary Sclerosing Cholangitis in the Absence of Inflammatory Bowel Disease Increases the Risk of Colorectal Cancer: A Multi\u2010Centre Propensity Score Matched Analysis. Aliment Pharmacol Ther. 2025;apt.70303. https:\/\/doi.org\/10.1111\/apt.70303","DOI":"10.1111\/apt.70303"},{"key":"9964_CR24","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/hepr.14029","volume":"54","author":"TS Das","year":"2024","unstructured":"Das TS, Ho K, Udaikumar J et al. Risk of colorectal cancer in patients with primary sclerosing cholangitis and concomitant inflammatory bowel disease compared with primary sclerosing cholangitis only. Hepatol Res. 2024;54:807\u2013816. https:\/\/doi.org\/10.1111\/hepr.14029.","journal-title":"Hepatol Res."},{"key":"9964_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/ecco-jcc\/jju013","volume":"9","author":"H Yanai","year":"2015","unstructured":"Yanai H, Matalon S, Rosenblatt A et al. Prognosis of Primary Sclerosing Cholangitis in Israel is Independent of Coexisting Inflammatory Bowel Disease. J Crohns Colitis. 2015;9:177\u2013184. https:\/\/doi.org\/10.1093\/ecco-jcc\/jju013.","journal-title":"J Crohns Colitis."},{"key":"9964_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.liver.2024.100244","volume":"16","author":"MJ Patel","year":"2024","unstructured":"Patel MJ, Zhang BY, Cotter TG, Anouti A. The effects of underlying inflammatory bowel disease on the outcomes of primary sclerosing cholangitis liver transplant recipients. J Liver Transplant. 2024;16:100244. https:\/\/doi.org\/10.1016\/j.liver.2024.100244.","journal-title":"J Liver Transplant."},{"key":"9964_CR27","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1007\/s12072-022-10356-1","volume":"16","author":"N Tan","year":"2022","unstructured":"Tan N, Ngu N, Worland T et al. Epidemiology and outcomes of primary sclerosing cholangitis: an Australian multicentre retrospective cohort study. Hepatol Int. 2022;16:1094\u20131104. https:\/\/doi.org\/10.1007\/s12072-022-10356-1.","journal-title":"Hepatol Int."},{"key":"9964_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1080\/00365521.2019.1707277","volume":"55","author":"N Barner-Rasmussen","year":"2020","unstructured":"Barner-Rasmussen N, Pukkala E, Jussila A, F\u00e4rkkil\u00e4 M. Epidemiology, risk of malignancy and patient survival in primary sclerosing cholangitis: a population-based study in Finland. Scand J Gastroenterol. 2020;55:74\u201381. https:\/\/doi.org\/10.1080\/00365521.2019.1707277.","journal-title":"Scand J Gastroenterol."},{"key":"9964_CR29","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00535-020-01663-1","volume":"55","author":"Z Bakhshi","year":"2020","unstructured":"Bakhshi Z, Hilscher MB, Gores GJ et al. An update on primary sclerosing cholangitis epidemiology, outcomes and quantification of alkaline phosphatase variability in a population-based cohort. J Gastroenterol. 2020;55:523\u2013532. https:\/\/doi.org\/10.1007\/s00535-020-01663-1.","journal-title":"J Gastroenterol."},{"key":"9964_CR30","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1002\/hep.30479","volume":"69","author":"EC Goode","year":"2019","unstructured":"Goode EC, Clark AB, Mells GF et al. Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System. Hepatology. 2019;69:2120\u20132135. https:\/\/doi.org\/10.1002\/hep.30479.","journal-title":"Hepatology."},{"key":"9964_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/lt.24350","volume":"22","author":"T Hildebrand","year":"2016","unstructured":"Hildebrand T, Pannicke N, Dechene A et al. Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis. Liver Transpl. 2016;22:42\u201352. https:\/\/doi.org\/10.1002\/lt.24350.","journal-title":"Liver Transpl."},{"key":"9964_CR32","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/LVT.0000000000000523","volume":"31","author":"MA Mouchli","year":"2025","unstructured":"Mouchli MA, Osman MK, Busebee B et al. Long-term (15 y) complications and outcomes after liver transplantation for primary sclerosing cholangitis: Impact of donor and recipient factors. Liver Transpl. 2025;31:781\u2013792. https:\/\/doi.org\/10.1097\/LVT.0000000000000523.","journal-title":"Liver Transpl."},{"key":"9964_CR33","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.jhep.2015.07.005","volume":"63","author":"R Ravikumar","year":"2015","unstructured":"Ravikumar R, Tsochatzis E, Jose S et al. Risk factors for recurrent primary sclerosing cholangitis after liver transplantation. J Hepatol. 2015;63:1139\u20131146. https:\/\/doi.org\/10.1016\/j.jhep.2015.07.005.","journal-title":"J Hepatol."},{"key":"9964_CR34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1155\/2010\/830291","volume":"24","author":"KJ Moncrief","year":"2010","unstructured":"Moncrief KJ, Savu A, Ma MM, Bain VG, Wong WW, Tandon P. The Natural History of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis after Liver Transplantation \u2013 a Single-Centre Experience. Can J Gastroenterol. 2010;24:40\u201346. https:\/\/doi.org\/10.1155\/2010\/830291.","journal-title":"Can J Gastroenterol."},{"key":"9964_CR35","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/00365521.2017.1421705","volume":"53","author":"L Lindstr\u00f6m","year":"2018","unstructured":"Lindstr\u00f6m L, J\u00f8rgensen KK, Boberg KM et al. Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study. Scand J Gastroenterol. 2018;53:297\u2013304. https:\/\/doi.org\/10.1080\/00365521.2017.1421705.","journal-title":"Scand J Gastroenterol."},{"key":"9964_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/lt.21313","volume":"14","author":"J Campsen","year":"2008","unstructured":"Campsen J, Zimmerman MA, Trotter JF et al. Clinically recurrent primary sclerosing cholangitis following liver transplantation: A time course. Liver Transpl. 2008;14:181\u2013185. https:\/\/doi.org\/10.1002\/lt.21313.","journal-title":"Liver Transpl."},{"key":"9964_CR37","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/tri.13852","volume":"34","author":"N Akamatsu","year":"2021","unstructured":"Akamatsu N, Hasegawa K, Egawa H et al. Donor age (\u226545 years) and reduced immunosuppression are associated with the recurrent primary sclerosing cholangitis after liver transplantation \u2013 a multicenter retrospective study. Transpl Int. 2021;34:916\u2013929. https:\/\/doi.org\/10.1111\/tri.13852.","journal-title":"Transpl Int."},{"key":"9964_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1478-3231.2011.02677.x","volume":"33","author":"D Joshi","year":"2013","unstructured":"Joshi D, Bjarnason I, Belgaumkar A et al. The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis. Liver Int. 2013;33:53\u201361. https:\/\/doi.org\/10.1111\/j.1478-3231.2011.02677.x.","journal-title":"Liver Int."},{"key":"9964_CR39","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","volume":"99","author":"K Burak","year":"2004","unstructured":"Burak K, Angulo P, Pasha TM, Egan K, Petz J, Lindor KD. Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis. Am J Gastroenterol. 2004;99:523\u2013526. https:\/\/doi.org\/10.1111\/j.1572-0241.2004.04067.x.","journal-title":"Am J Gastroenterol."},{"key":"9964_CR40","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/ajg.2016.55","volume":"111","author":"AF Gulamhusein","year":"2016","unstructured":"Gulamhusein AF, Eaton JE, Tabibian JH, Atkinson EJ, Juran BD, Lazaridis KN. Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD. Am J Gastroenterol. 2016;111:705\u2013711. https:\/\/doi.org\/10.1038\/ajg.2016.55.","journal-title":"Am J Gastroenterol."},{"key":"9964_CR41","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/lt.24496","volume":"22","author":"FD Gordon","year":"2016","unstructured":"Gordon FD, Goldberg DS, Goodrich NP et al. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients. Liver Transplant. 2016;22:1214\u20131222. https:\/\/doi.org\/10.1002\/lt.24496.","journal-title":"Liver Transplant."},{"key":"9964_CR42","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000006533","author":"AJ Matar","year":"2024","unstructured":"Matar AJ, Falconer E, LaBella M et al. Long-term Outcomes Following Colectomy and Liver Transplantation for Inflammatory Bowel Disease with Primary Sclerosing Cholangitis. Ann Surg. 2024. https:\/\/doi.org\/10.1097\/SLA.0000000000006533.","journal-title":"Ann Surg."},{"key":"9964_CR43","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/apt.14393","volume":"47","author":"C Nordenvall","year":"2018","unstructured":"Nordenvall C, Ol\u00e9n O, Nilsson PJ et al. Colectomy prior to diagnosis of primary sclerosing cholangitis is associated with improved prognosis in a nationwide cohort study of 2594 PSC-IBD patients. Aliment Pharmacol Ther. 2018;47:238\u2013245. https:\/\/doi.org\/10.1111\/apt.14393.","journal-title":"Aliment Pharmacol Ther."},{"key":"9964_CR44","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1007\/s10620-023-08023-y","volume":"68","author":"DU Lee","year":"2023","unstructured":"Lee DU, Menegas S, Lee KJ et al. Impact of Inflammatory Bowel Disease Subtypes on the Post-liver Transplant Outcomes of Patients with Primary Sclerosing Cholangitis. Dig Dis Sci. 2023;68:3781\u20133800. https:\/\/doi.org\/10.1007\/s10620-023-08023-y.","journal-title":"Dig Dis Sci."},{"key":"9964_CR45","doi-asserted-by":"publisher","unstructured":"Niu C, Zhang J, Bhatta P, et al. Coexisting inflammatory bowel disease in primary sclerosing cholangitis is associated with higher colorectal cancer and transplant risk. J Intern Med. 2025;joim.70026. https:\/\/doi.org\/10.1111\/joim.70026","DOI":"10.1111\/joim.70026"},{"key":"9964_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100599","volume":"4","author":"T Visseren","year":"2022","unstructured":"Visseren T, Erler NS, Heimbach JK et al. Inflammatory conditions play a role in recurrence of PSC after liver transplantation: An international multicentre study. JHEP Reports. 2022;4:100599. https:\/\/doi.org\/10.1016\/j.jhepr.2022.100599.","journal-title":"JHEP Reports."},{"key":"9964_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101272","volume":"7","author":"KK Leung","year":"2024","unstructured":"Leung KK, Li W, Hansen B et al. Primary sclerosing cholangitis-inflammatory bowel disease: Epidemiology, mortality, and impact of diagnostic sequence. JHEP Rep. 2024;7:101272. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101272.","journal-title":"JHEP Rep."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-09964-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-09964-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-09964-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:15:28Z","timestamp":1787800528000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-09964-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["9964"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-09964-w","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"4 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this project involved only publicly available data, ethics approval was not required. The study adheres to the principles of the Helsinki Declaration.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}